| Literature DB >> 32789196 |
Rahul Verma1,2, Yasna Mehdian3, Neel Sheth4, Kathy Netten5, Jean Vinette5, Ashley Edwards5, Joanna Polyviou6, Julia Orkin7,8,9, Reshma Amin6,8,9.
Abstract
OBJECTIVE: To quantify psychosocial risk in family caregivers of children with medical complexity using the Psychosocial Assessment Tool (PAT) and to investigate potential contributing sociodemographic factors.Entities:
Keywords: intensive care; psychology; respiratory; screening; social work
Year: 2020 PMID: 32789196 PMCID: PMC7389766 DOI: 10.1136/bmjpo-2020-000671
Source DB: PubMed Journal: BMJ Paediatr Open ISSN: 2399-9772
Descriptive statistics for PAT total scores and subscale scores (n=136)
| PAT scale (items) | Scale range | Mean | SD | Range |
| Total | 0–7 | 1.17 | 0.74 | 0–3.92 |
| Family structure/resources(education, marital status, 1, 3, 6, 7) | 0–7 | 0.17 | 0.16 | 0–0.71 |
| Social support (2a-d) | 0–4 | 0.09 | 0.22 | 0–1.00 |
| Child problems (9a-d, k-u, w) | 0–16 | 0.29 | 0.20 | 0–0.88 |
| Sibling problems(10a-d, g-u, w) | 0–20 | 0.08 | 0.13 | 0–0.69 |
| Caregiver problems(11a-e, g-j, l) | 0–10 | 0.22 | 0.19 | 0–0.90 |
| Caregiver stress reactions(12a-e) | 0–5 | 0.20 | 0.29 | 0–1.00 |
| Family beliefs(14a-l) | 0–12 | 0.12 | 0.11 | 0–0.67 |
PAT, Psychosocial Assessment Tool.
Comparison of family caregivers’ PAT scores from other paediatric populations with this study
| Study | Population | Universal n (%) | Targeted n (%) | Clinical n (%) | Mean PAT score | 95% CI of the difference | P value |
| Verma | Children with medical complexity | 61 (45%) | 60 (44%) | 15 (11%) | 1.17 | ||
| Reader | Sickle cell disease | 63 (46%) | 54 (40%) | 19 (14%) | 1.15 | 0.16 to 0.20 | 0.8 |
| Sharkey | Cancer | NR | NR | NR | 1.02 | 0.00 to 0.30 | 0.05 |
| Tsumura | Cancer | NR | NR | NR | 1.45 | −0.48 to 0.0.8 | 0.006 |
| Filigno | Cystic fibrosis | 80 (52%) | 63 (41%) | 11 (7%) | 1.00 | 0.00 to 0.34 | 0.05 |
| Kapa | Craniofacial | NR | NR | NR | 0.91 | 0.10 to 0.42 | 0.001 |
| Law | Headache | 134 (57%) | 82 (35%) | 19 (8%) | 0.99 | 0.04 to 0.33 | 0.02 |
| Rocque | Brain tumour | 24 (60%) | 15 (38%) | 1 (2%) | 0.89 | 0.03 to 0.52 | 0.03 |
| Pai | Stem cell transplant | 76 (54%) | 42 (30%) | 22 (16%) | 1.14 | −0.15 to 0.21 | 0.7 |
| Schulte | Cancer | NR | NR | NR | 0.84 | 0.14 to 0.52 | <0.001 |
| Crerand | Craniofacial | 130 (60%) | 70 (32%) | 17 (8%) | 0.91 | 0.11 to 0.41 | <0.001 |
| Ernst | Disorders of sexual development | 130 (66%) | 55 (28%) | 12 (6%) | 0.86 | 0.16 to 0.46 | <0.001 |
| Kazak | Cancer | 246 (62%) | 106 (27%) | 42 (11%) | 0.97 | 0.06 to 0.34 | 0.005 |
| Cousino | Heart transplant | 33 (59%) | 17 (30%) | 6 (11%) | 0.96 | 0.02 to 0.44 | 0.08 |
| Phan | Obesity | 7 (27%) | 17 (65%) | 2 (8%) | 1.20 | −0.20 to 0.14 | 0.7 |
| Woods and Ostrowski-Delahanty | Headache | NR | NR | NR | 1.12 | −0.12 to 0.22 | 0.6 |
| Clapin | Type 1 diabetes | NR | NR | NR | 1.00 | 0.07 to 0.41 | 0.2 |
| Pierce | Cancer | 42 (63%) | 21 (31%) | 4 (6%) | 0.90 | 0.06 to 0.48 | 0.01 |
| McCarthy | Cancer | 51 (57%) | 34 (38%) | 4 (5%) | 1.00 | −0.01 to 0.35 | 0.07 |
| Sint Nicolaas | Cancer | 77 (66%) | 34 (29%) | 6 (5%) | 0.80 | 0.20 to 0.54 | <0.001 |
| Pai | Inflammatory bowel disease | 27 (64%) | 15 (36%) | 0 (0%) | 0.77 | 0.21 to 0.59 | <0.001 |
| Barrera | Cancer | 40 (60%) | 21 (31%) | 6 (9%) | NR | ||
| Hearps | Congenital heart disease | 24 (62%) | 14 (36%) | 1 (2%) | 0.81 | 0.14 to 0.58 | 0.001 |
| Karlson | Sickle cell disease | 109 (50%) | 80 (36%) | 30 (14%) | 1.12 | −0.11 to 0.21 | 0.5 |
| Pai | Kidney transplant | NR | NR | NR | 0.98 | −0.06 to 0.44 | 0.1 |
| Kazak | Cancer | 36 (72%) | 12 (24%) | 2 (4%) | 0.76 | 0.20 to 0.62 | <0.001 |
| McCarthy | Cancer | 147 (67%) | 52 (24%) | 21 (9%) | 0.93 | 0.21 to 0.51 | <0.001 |
| Alderfer | Cancer | 51 (50%) | 42 (41%) | 9 (9%) | NR | ||
| Pai | Cancer | 122 (59%) | 65 (32%) | 18 (9%) | 1.02 | −0.01 to 0.31 | 0.07 |
P values were obtained by performing independent t-tests to compare each study with the current study; p values were corrected using the Šidák correction for multiple comparisons.
NR, not reported; PAT, Psychosocial Assessment Tool.
Summary of multiple regression analysis of caregivers’ sociodemographic factors on total PAT scores
| Variable | B coefficient | SE | 95% CI | P value |
| Child’s hospitalisation days in previous year (0–1 days) | −0.30 | 0.19 | −0.68 to 0.08 | 0.1 |
| Child’s hospitalisation days in previous year (2–10 days) | −0.28 | 0.21 | −0.69 to 0.13 | 0.2 |
| Child’s hospitalisation days in previous year (>10 days) | Reference | – | – | – |
| Paid homecare support (0 hours/week) | −0.37 | 0.22 | −0.81 to 0.07 | 0.1 |
| Paid homecare support (1–19 hours/week) | −0.30 | 0.26 | −0.83 to 0.22 | 0.3 |
| Paid homecare support (20–49 hours/week) | −0.23 | 0.22 | −0.65 to 0.20 | 0.3 |
| Paid homecare support (>50 hours/week) | Reference | – | – | – |
| Caregiver employment status (full-time) | −0.21 | 0.17 | −0.55 to 0.14 | 0.2 |
| Caregiver employment status (part-time) | −0.30 | 0.24 | −0.78 to 0.18 | 0.2 |
| Caregiver employment status (unemployed) | 0.16 | 0.18 | −0.20 to 0.52 | 0.4 |
| Caregiver employment status (did not disclose) | Reference | – | – | – |
| Caregiver sex | 0.19 | 0.16 | −0.12 to 0.50 | 0.2 |
| Number of medical technologies | −0.01 | 0.41 | −0.09 to 0.07 | 0.8 |
PAT, Psychosocial Assessment Tool.
Demographic characteristics of the 136 family caregivers included in this study
| Gender | n=136 |
| Female | 103 (76%) |
| Male | 32 (23%) |
| Did not disclose | 1 (1%) |
| Age (years) | |
| 20–29 | 6 (4%) |
| 30–39 | 46 (34%) |
| 40–49 | 56 (41%) |
| 50–59 | 19 (14%) |
| 60–69 | 3 (2%) |
| 70–79 | 1 (1%) |
| Did not disclose | 5 (4%) |
| Ethnicity (mother) | |
| European | 57 (42%) |
| Asian | 50 (37%) |
| Caribbean/Indian-Caribbean | 11 (8%) |
| Other | 11 (8%) |
| African | 7 (5%) |
| Ethnicity (father) | |
| European | 55 (40%) |
| Asian | 46 (34%) |
| Other | 15 (11%) |
| Caribbean/Indian-Caribbean | 12 (9%) |
| African | 8 (6%) |
| Marital status | |
| Single or separated | 31 (23%) |
| Married/Partnered | 104 (76%) |
| Did not disclose | 1 (1%) |
| Education | |
| Started high school | 7 (5%) |
| Graduated high school | 19 (14%) |
| Some tertiary study | 23 (17%) |
| Finished college or trade school | 68 (50%) |
| Finished Master’s or Doctoral programme | 17 (13%) |
| Did not disclose | 2 (1%) |
| Relation to child | |
| Biological parent | 126 (93%) |
| Grandparent | 4 (3%) |
| Foster parent | 3 (2%) |
| Aunt/Uncle/Other relative | 2 (1%) |
| Step parent | 1 (1%) |
| Role with child | |
| Primary (daily) caregiver | 128 (94%) |
| Supporting/Back-up caregiver | 5 (4%) |
| Occasional caregiver | 2 (1%) |
| Other | 1 (1%) |
| Caregivers at home | |
| 1 | 17 (12%) |
| 2 | 95 (70%) |
| ≥3 | 24 (18%) |
| After-tax income (US$) | |
| <30 000 | 27 (20%) |
| 30 000–79 999 | 49 (36%) |
| 80 000–149 999 | 29 (21%) |
| ≥150 000 | 11 (8%) |
| Did not disclose | 20 (15%) |
| Employment status | |
| Full-time | 54 (40%) |
| Part-time | 13 (9%) |
| Unemployed | 42 (31%) |
| Did not disclose | 27 (20%) |
| Financial difficulty | |
| No problems | 62 (46%) |
| Some problems | 49 (36%) |
| Difficulty meeting family needs | 25 (18%) |
Demographic and disease characteristics of the 136 children with medical complexity at the time of their clinic visit
| Gender | n=136 |
| Male | 86 (63%) |
| Female | 50 (37%) |
| Age (years) | |
| 0–4 | 34 (25%) |
| 5–9 | 33 (24%) |
| 10–14 | 39 (29%) |
| 15–18 | 30 (22%) |
| Primary diagnosis | |
| Central nervous system (n=38%–28%) | |
| Congenital central hypoventilation syndrome | 9 (7%) |
| Spinal injury | 6 (4%) |
| Birth injury/cerebral palsy | 5 (4%) |
| Acquired central hypoventilation syndrome | 3 (2%) |
| Other central causes | 15 (11%) |
| Musculoskeletal (n=82%–61%) | |
| Duchenne’s muscular dystrophy | 19 (14%) |
| Other dystrophy | 18 (13%) |
| Spinal muscular atrophy | 13 (10%) |
| Congenital myopathy | 8 (6%) |
| Other myopathy | 8 (6%) |
| Mucopolysaccharidoses | 3 (2%) |
| Other musculoskeletal | 13 (10%) |
| Respiratory (n=10%–7%) | |
| Upper airway obstruction | 4 (3%) |
| Chronic lung disease | 3 (2%) |
| Airway malacia | 1 (1%) |
| Other respiratory | 2 (1%) |
| Unclassified (n=6%–4%) | |
| Days in hospital in the past 12 months | |
| 0–1 | 81 (59%) |
| 2–10 | 34 (26%) |
| >10 | 21 (15%) |
| Paid homecare support* (hours/week) | |
| 0 | 73 (54%) |
| 1–19 | 14 (10%) |
| 20–49 | 27 (20%) |
| >50 | 22 (16%) |
| Number of technologies | |
| 0–1 | 37 (27%) |
| 2–4 | 57 (42%) |
| ≥5 | 42 (31%) |
| Technology | |
| Oxygen saturation monitor | 79 (58%) |
| Wheelchair | 79 (58%) |
| BiPAP (nocturnal) | 52 (38.%) |
| Cough assist | 51 (38%) |
| Suction | 49 (36%) |
| Gastrostomy tube | 37 (27%) |
| Supplemental oxygen (nocturnal/naps) | 19 (14%) |
| Trach/Vent (nocturnal/naps) | 18 (13%) |
| Gastrojejunostomy tube | 17 (13%) |
| Trach/Vent (24 hours/day) | 9 (7%) |
| Trach only | 6 (4%) |
| Supplemental oxygen (24 hours) | 3 (2%) |
| Ventriculoperitoneal shunt | 3 (2%) |
| CPAP | 2 (1%) |
| Lifting device | 2 (1%) |
| Sip ventilation | 1 (1%) |
| Port-a-Cath | 1 (1%) |
*Homecare supports included the number of nursing and personal support worker hours per week.
BiPAP, Bilevel positive airway pressure; CPAP, continuous positive airway pressure; Trach/Vent, tracheostomy and ventilation.